Evidence of increased CXCL16 and CXCR6 expression at the site of inflammation was reported previously in the context of RA and psoriasis, and CXCL16 was shown to enhance recruitment of inflamed tissue‐derived CXCR6‐expressing T cells 41, 42, 43. Here, CXCL16 is linked to rheumatoid arthritis.